Patents Examined by Mary C. Cebuilak
  • Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
    Patent number: 5714493
    Abstract: This invention relates to the treatment of intimation in a patient suffering from such disorder. More specifically, the invention relates to mono- and/or bicyclic aryl or heteroaryl quinazoline compounds in the treatment of inflammation.
    Type: Grant
    Filed: June 4, 1996
    Date of Patent: February 3, 1998
    Assignee: Rhone-Poulenc Rorer Pharmaceuticals, Inc.
    Inventors: Michael R. Myers, Alfred P. Spada, Martin P. Maguire, Paul E. Persons, Asher Zilberstein, Chin-Yi Jenny Hsu, Susan E. Johnson